86 related articles for article (PubMed ID: 15812606)
1. Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial.
Rufer M; Hand I; Alsleben H; Braatz A; Ortmann J; Katenkamp B; Fricke S; Peter H
Eur Arch Psychiatry Clin Neurosci; 2005 Apr; 255(2):121-8. PubMed ID: 15812606
[TBL] [Abstract][Full Text] [Related]
2. Early maladaptive schemas impact on long-term outcome in patients treated with group behavioral therapy for obsessive-compulsive disorder.
Sunde T; Hummelen B; Himle JA; Walseth LT; Vogel PA; Launes G; Haaland VØ; Haaland ÅT
BMC Psychiatry; 2019 Oct; 19(1):318. PubMed ID: 31655556
[TBL] [Abstract][Full Text] [Related]
3. Cognitive and clinical predictors of a long-term course in obsessive compulsive disorder: A machine learning approach in a prospective cohort study.
Segalàs C; Cernadas E; Puialto M; Fernández-Delgado M; Arrojo M; Bertolin S; Real E; Menchón JM; Carracedo A; Tubío-Fungueiriño M; Alonso P; Fernández-Prieto M
J Affect Disord; 2024 Apr; 350():648-655. PubMed ID: 38246282
[TBL] [Abstract][Full Text] [Related]
4. Long-term remission rates and trajectory predictors in obsessive-compulsive disorder: Findings from a six-year naturalistic longitudinal cohort study.
Geiger Y; van Oppen P; Visser H; Eikelenboom M; van den Heuvel OA; Anholt GE
J Affect Disord; 2024 Apr; 350():877-886. PubMed ID: 38266929
[TBL] [Abstract][Full Text] [Related]
5. [Intensive exposure treatment for obsessive compulsive disorder in old age.].
Guineau MG; Oude Voshaar RC; Hendriks GJ
Tijdschr Psychiatr; 2024; 66(3):168-171. PubMed ID: 38650516
[TBL] [Abstract][Full Text] [Related]
6. Clinical case report: considerable improvement of severe and difficult-to-treat obsessive-compulsive disorder with comorbid depression under treatment with esketamine and concomitant psychotherapy.
Kaltenboeck A; Foerster E; Strafner S; Demal U; Mossaheb N; Friedrich F
Front Psychiatry; 2023; 14():1291077. PubMed ID: 38090708
[TBL] [Abstract][Full Text] [Related]
7. Long-term effectiveness and cost-effectiveness of guided internet-based cognitive behavioral therapy for obsessive-compulsive disorder: 24-month follow-up.
Matsumoto K; Hamatani S; Shimizu E
Internet Interv; 2024 Mar; 35():100725. PubMed ID: 38362159
[TBL] [Abstract][Full Text] [Related]
8. [Experience of clinical use of fluvoxamine for the treatment of comorbid depression in childhood and adolescence].
Goryunov AV; Golubeva NI; Shushpanova OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(11. Vyp. 2):14-21. PubMed ID: 38127696
[TBL] [Abstract][Full Text] [Related]
9. Primary obsessive slowness in a young woman who benefited from continuous psychoeducation and modeling with video recordings during hospitalization: a case report.
Inagaki T; Funada D; Imamura F; Mitamura Y; Murata Y; Yoshimura N; Kito S
BMC Psychiatry; 2024 May; 24(1):375. PubMed ID: 38773509
[TBL] [Abstract][Full Text] [Related]
10. Is ECT effective in treatment-refractory OCD? Concerns with the data and analysis of a recently published randomized-controlled trial.
Arumugham SS; Thirthalli J; Reddy YCJ
J Affect Disord; 2024 Jan; 344():617-618. PubMed ID: 37863365
[No Abstract] [Full Text] [Related]
11. Long-term effects of the treatment of depressive female inpatients in a naturalistic study: is early improvement a valid predictor of outcome?
Zuercher-Huerlimann E; Grosse Holtforth M; Hermann E
Depress Res Treat; 2014; 2014():780237. PubMed ID: 25061526
[TBL] [Abstract][Full Text] [Related]
12. Response to "
Fung R; Elbe D; Stewart SE
J Can Acad Child Adolesc Psychiatry; 2021 Nov; 30(4):278-279. PubMed ID: 34777511
[No Abstract] [Full Text] [Related]
13. Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder.
O'Connor KP; Aardema F; Robillard S; Guay S; Pélissier MC; Todorov C; Borgeat F; Leblanc V; Grenier S; Doucet P
Acta Psychiatr Scand; 2006 May; 113(5):408-19. PubMed ID: 16603032
[TBL] [Abstract][Full Text] [Related]
14. Response versus remission in obsessive-compulsive disorder.
Simpson HB; Huppert JD; Petkova E; Foa EB; Liebowitz MR
J Clin Psychiatry; 2006 Feb; 67(2):269-76. PubMed ID: 16566623
[TBL] [Abstract][Full Text] [Related]
15. Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up.
van Oppen P; van Balkom AJ; de Haan E; van Dyck R
J Clin Psychiatry; 2005 Nov; 66(11):1415-22. PubMed ID: 16420079
[TBL] [Abstract][Full Text] [Related]
16. Treatment of obsessive-compulsive disorder: cognitive behavior therapy vs. exposure and response prevention.
Whittal ML; Thordarson DS; McLean PD
Behav Res Ther; 2005 Dec; 43(12):1559-76. PubMed ID: 15913543
[TBL] [Abstract][Full Text] [Related]
17. Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder.
van Balkom AJ; de Haan E; van Oppen P; Spinhoven P; Hoogduin KA; van Dyck R
J Nerv Ment Dis; 1998 Aug; 186(8):492-9. PubMed ID: 9717867
[TBL] [Abstract][Full Text] [Related]
18. Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy.
de Haan E; van Oppen P; van Balkom AJ; Spinhoven P; Hoogduin KA; Van Dyck R
Acta Psychiatr Scand; 1997 Nov; 96(5):354-61. PubMed ID: 9395153
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Stability of Benefits of Cognitive Behavioral Therapy for Obsessive Compulsive Disorder Depends on Symptom Remission During Treatment.
Elsner B; Wolfsberger F; Srp J; Windsheimer A; Becker L; Jacobi T; Kathmann N; Reuter B
Clin Psychol Eur; 2020 Mar; 2(1):e2785. PubMed ID: 36397977
[TBL] [Abstract][Full Text] [Related]
20. Antiglutamatergic agents for obsessive-compulsive disorder: Where are we now and what are possible future prospects?
Maraone A; Tarsitani L; Pinucci I; Pasquini M
World J Psychiatry; 2021 Sep; 11(9):568-580. PubMed ID: 34631461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
